{
  "calculators": [
    {
      "id": "pediatric-glasgow-coma-scale",
      "title": "Pediatric Glasgow Coma Scale",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Eye Opening",
          "data": [
            {
              "type": "radio",
              "label": "Open spontaneously",
              "points": "4"
            },
            {
              "type": "radio",
              "label": "Open to verbal stimuli",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "Open to pain only",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "No response",
              "points": "1"
            }
          ]
        },
        {
          "group": "Verbal Responses",
          "data": [
            {
              "type": "radio",
              "label": "Coos and babbles",
              "points": "5"
            },
            {
              "type": "radio",
              "label": "Irritable cries",
              "points": "4"
            },
            {
              "type": "radio",
              "label": "Cries in response to pain",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "Moans in response to pain",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "No response",
              "points": "1"
            }
          ]
        },
        {
          "group": "Motor Responses",
          "data": [
            {
              "type": "radio",
              "label": "Moves spontaneously/purposefully",
              "points": "6"
            },
            {
              "type": "radio",
              "label": "Withdraws to touch",
              "points": "5"
            },
            {
              "type": "radio",
              "label": "Withdraws to pain",
              "points": "4"
            },
            {
              "type": "radio",
              "label": "Flexor posturing to pain",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "Extensor posturing to pain",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "No response",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "3 - 8": ["Severe head injury (coma)"],
          "9 - 12": ["Moderate head injury"],
          "13 - 15": ["Minor head injury"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "For use only in children 2 years and younger. For children >2 years use the adult Glasgow Coma Scale",
            "The pediatric GCS can be used to assess and track a patient's mental status and level of consciousness but should not be used alone in determining management decisions in acute care settings",
            "All patients with pGCS < 15 need appropriate monitoring",
            "For patients with pGCS < 8, consider the need for intubation or definitive airway management. Take into account the entire clinical picture"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "James HE, Neurologic evaluation and support in the child with an acute brain insult. Pediatr Ann. 1986 Jan;15(1):16-22.",
            "Borgialli DA, Mahajan P. et al. Performance of the Pediatric Glasgow Coma Scale Score in the Evaluation of Children With Blunt Head Trauma. Acad Emerg Med. 2016 Aug;23(8):878-84."
          ]
        }
      ]
    },
    {
      "id": "bode-index-copd",
      "title": "BODE Index for COPD Survival Prediction",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria"
        },
        {
          "group": "FEV1 % Predicted After Bronchodialator",
          "data": [
            {
              "type": "radio",
              "label": "≥65%",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "50-64%",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "36-49%",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≤35%",
              "points": "3"
            }
          ]
        },
        {
          "group": "6 min Walk Distance",
          "data": [
            {
              "type": "radio",
              "label": "≥350m",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "250-349m",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "150-249m",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≤149m",
              "points": "3"
            }
          ]
        },
        {
          "group": "mMRC Dyspnea Scale",
          "data": [
            {
              "type": "radio",
              "label": "mMRC 0: Dyspnea only with strenous exercise",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "mMRC 1: Dyspnea when hurrying or walking a slight hill",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "mMRC 2: Stops for breath when walking at own pace on level ground",
              "points": 1
            },
            {
              "type": "radio",
              "label": "mMRC 3: Must stop due to breathlessness after walking 91m or after a few minutes",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "mMRC 4: Cannot leave house, breathless on dressing/undressing",
              "points": "3"
            }
          ]
        },
        {
          "group": "Body Mass Index",
          "data": [
            {
              "type": "radio",
              "label": ">21",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "≤21",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0 - 2": [
          "Approximate 4 year survival: 80%"
        ],
        "3 - 4": [
          "Approximate 4 year survival: 67%"
        ],
        "5 - 6": [
          "Approximate 4 year survival: 57%"
        ],
        "7 - 10": [
          "Approximate 4 year survival: 18%"
        ]
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "BODE stands for Body mass index, airflow Obsruction, Dyspnea and Exercise capacity",
          "Used to predict survival in COPD patients but is not suitable to guide therapy or management",
          "BODE index is best used to help inform discussions with patients on their prognosis and goals of care",
          "Should not be used during acute exacerbations of COPD and it does not predict clinical response to therapy",
          "Patients with a higher BODE index have a higher risk of death from respiratory causes (e.g. respiratory failure, pneumonia, or pulmonary embolism)"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Celli BR, Cote CG, Marin JM, et. al. The Body-Mass Index, Airflow Obstruction, Dyspnea and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004 Mar 4;350(10):1005-12.",
          "Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988 Mar;93(3):580-6.",
          "Marin JM, Carrizo SJ, Casanova C., et. al. Prediction of risk of COPD exacerbations by the BODE index. respir Med. 2009; 103(3):373-8"
        ]
      }
    },
    {
      "id": "pulmonary-embolism-wells-score",
      "title": "Pulmonary Embolism Wells Score",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Clinical symptoms of DVT",
              "points": "3"
            },
            {
              "type": "checkbox",
              "label": "No alternative diagnosis better explains the illness",
              "points": "3"
            },
            {
              "type": "checkbox",
              "label": "Pulse > 100bpm",
              "points": "1.5"
            },
            {
              "type": "checkbox",
              "label": "Immobilization for ≥3 days or surgery in last 4 weeks",
              "points": "1.5"
            },
            {
              "type": "checkbox",
              "label": "Prior history of DVT or Pulmonary Embolism",
              "points": "1.5"
            },
            {
              "type": "checkbox",
              "label": "Hemoptysis",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Malignancy with treatment within 6 months",
              "points": "1"
            }
          ]
        }
      ],
      "results": {
        "0 - 1.5": "Risk: Low probability of Pulmonary Embolism. Consider d-dimer testing to rule out PE",
        "2 - 6": "Risk: Moderate probability of Pulmonary Embolism. Consider high sensitivity d-dimer testing",
        "7 - 13": "Risk: High probability of Pulmonary Embolism. Consider "
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "The Wells Score helps to stratify the risk of pulmonary embolism and is often used in conjunction with d-dimer testing to evaluate for PE",
          "It is not intended to diagnose pulmonary embolisms but to help guide clinical workup by predicting pre-test probability of PE and appropriate testing to rule out the diagnosis"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Wells PS, Anderson DR, Rodger M, et. al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000 Mar;83(3):416-20."
        ]
      }
    },
    {
      "id": "heart-score-major-cardiac-events",
      "title": "HEART Score for Major Cardiac Events",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "History",
          "data": [
            {
              "type": "radio",
              "label": "Slightly suspicious",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Moderately suspicious",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Highly suspicious",
              "points": "2"
            }
          ]
        },
        {
          "group": "EKG",
          "data": [
            {
              "type": "radio",
              "label": "Normal",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Non-specific repolarization disturbance",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Significant ST depression",
              "points": "2"
            }
          ]
        },
        {
          "group": "Age",
          "data": [
            {
              "type": "radio",
              "label": "<45",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "45-65",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "≥65",
              "points": "2"
            }
          ]
        },
        {
          "group": "Risk factors",
          "data": [
            {
              "type": "radio",
              "label": "No known risk factors",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "1-2 risk factors",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "≥3 risk factors or history of atherosclerotic disease",
              "points": "2"
            }
          ]
        },
        {
          "group": "Initial Troponin",
          "data": [
            {
              "type": "radio",
              "label": "≤ Normal limit",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "1-2X Normal limit",
              "points": "1"
            },
            {
              "type": "radio",
              "label": ">2X Normal limit",
              "points": "2"
            }
          ]
        }
      ],
      "results": {
        "0 - 3": "Low Risk: 0.9-1.7% risk of adverse cardiac event. In the HEART Score study, these patients were discharged (0.99% in the retrospective study, 1.7% in the prospective study)",
        "4 - 6": "Moderate Risk: 12-16.6% risk of adverse cardiac event. In the HEART Score study, these patients were admitted to the hospital. (11.6% retrospective, 16.6% prospective)",
        "7 - 10": "High risk: 50-65% risk of adverse cardiac event. In the HEART Score study, these patients were candidates for early invasive measures. (65.2% retrospective, 50.1% prospective)"
      },
      "notes": {
        "type": "unordered-list",
        "content": [
          "The HEART score was developed in 2008 in a cohort of 122 patients presenting with chest pain in an emergency room",
          "Use in patients ≥ 21 years old presenting with symptoms suggestive of Acute Coronary Syndrome",
          "Do not use on clinically unstable patients or if new ST-segment elevation requires immediate intervention (i.e.≥ 1mm)"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Six, AJ., Backus, BE., Kelder, JC., Chest pain in the emergency room: value of the HEART Score. Neth Neart J. 2008 June; 16(6):191-196"
        ]
      }
    },
    {
      "id": "quick-sofa-score-sepsis",
      "title": "qSOFA Score for Sepsis",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Altered mental status GCS <15",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Respiratory rate ≥ 22",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Systolic BP ≤ 100mmHg",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 1": [
            "Not High Risk; If sepsis is still suspected, continue to monitor, evaluate and initiate treatment as appropriate"
          ],
          "2 - 3": [
            "High Risk: Patients meeting this qSOFA criteria should have infection considered even if it was previously not suspected. Assess for evidence of organ dysfunction with blood test including serum lactate. Calculate full SOFA Score"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "qSOFA helps to identify high risk patients for inpatient mortality with suspected infection outside the ICU",
          "This calculator is used to predict mortality and not to diagnose sepsis, per 2017 Surviving Sepsis Guidelines",
          "A positive qSOFA Score (≥2 points) may suggest a high risk of poor outcome in patients with suspected infection",
          "However a positive qSOFA Score alone should not trigger sepsis-directed interventions like initiation of broad spectrum antibiotics. It should instead prompt further investigation of the presence of organ dysfunction or to increase frequency of monitoring ",
          "The Sepsis 3 task force recommends that a positive qSOFA Score should prompt the calculation of a SOFA score to confirm the diagnosis of sepsis"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Seymour CW, Liu VX, Iwashyna TJ, et. al. Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA. 2016; 315(8):762-774",
          "Rhodes A, Evans LE, Alhazzani W, et. al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock. Crit Care Med. 2017, Mar;45(3):486-552"
        ]
      }
    },
    {
      "id": "child-pugh-score-cirrhosis-mortality",
      "title": "Child-Pugh Score for Cirrhosis Mortality",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Bilirubin",
          "data": [
            {
              "type": "radio",
              "label": "<2mg/dL (<34.2µmol/L)",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "2-3mg/dL (34.2-51.3µmol/L)",
              "points": "2"
            },
            {
              "type": "radio",
              "label": ">3mg/dL (>51.3µmol/L)",
              "points": "3"
            }
          ]
        },
        {
          "group": "Albumin",
          "data": [
            {
              "type": "radio",
              "label": ">3.5g/dL (>35g/L)",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "2.8-3.5g/dL (28-35 g/L)",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "<2.8 g/dL (<28g/L)",
              "points": "3"
            }
          ]
        },
        {
          "group": "INR",
          "data": [
            {
              "type": "radio",
              "label": "<1.7",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "1.7-2.2",
              "points": "2"
            },
            {
              "type": "radio",
              "label": ">2.2",
              "points": "3"
            }
          ]
        },
        {
          "group": "Ascites",
          "data": [
            {
              "type": "radio",
              "label": "Absent",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Slight",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "Moderate",
              "points": "3"
            }
          ]
        },
        {
          "group": "Encephalopathy",
          "data": [
            {
              "type": "radio",
              "label": "No Encephalopathy",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Grade 1-2",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "Grade 3-4",
              "points": "3"
            }
          ]
        }
      ],
      "results": [
        {
          "5 - 6": [
            "Child Class A; Life expectancy: 15-20 years; Abdominal surgery peri-operative mortality: 10%"
          ],
          "7 - 9": [
            "Child Class B; Indication for transplant evaluation; Abdominal surgery peri-operative mortality: 30%"
          ],
          "10 - 15": [
            "Child Class C; Life expectancy: 1-3 years; Abdominal surgery peri-operative mortality: 82%"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "The Child-Pugh Score is used to estimate the severity of cirrhosis",
          "Consider comparing patients with unexpectedly high or low Child scores with another score like the MELD score."
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Child CG, Turcotte JG. Surgery and portal hypertension. In: The liver and portal hypertension. Edited by CG Child. Philadelphia: Saunders 1964:50-64."
        ]
      }
    },
    {
      "id": "intracranial-bleeding-risk-thrombolytic-therapy-of-mi",
      "title": "Intracranial Bleeding Risk From Thrombolytic Therapy of MI",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Patient is ≥75 years",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient ethnic group is Black",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Female Patient",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Prior history of stroke",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Systolic Blood Pressure ≥ 160 mmHg",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Body weight ≤65kg for Female, ≤80kg for Male patients",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "INR >4 or prothrombin time >24 secs",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "TPA used instead of another thrombolytic",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 1": [
            "Risk of Cerebral Bleeding: 0.69%"
          ],
          "2": [
            "Risk of Cerebral Bleeding: 1.02%"
          ],
          "3": [
            "Risk of Cerebral Bleeding: 1.63%"
          ],
          "4": [
            "Risk of Cerebral Bleeding: 2.49%"
          ],
          "5 - 8": [
            "Risk of Cerebral Bleeding: 4.11%"
          ]
        }
      ],
      "references": {
        "type": "ordered-list",
        "content": [
          "Brass LM, Lichtman JH, Wang Y, et al. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction. Stroke. 2000; 31: 1802-11."
        ]
      }
    },
    {
      "id": "killip-class-heart-failure",
      "title": "Killip Classification for Heart Failure",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Classification",
          "data": [
            {
              "type": "radio",
              "label": "No signs of congestion",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "S3 and Basal rales on auscultation",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "Acute pulmonary edema",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "Cardiogenic shock with rales",
              "points": "4"
            }
          ],
          "results": [
            {
              "1": [
                "Killip Class I: Estimated 30-day mortality: 2-3%"
              ],
              "2": [
                "Killip Class II: Estimated 30-day mortality: 5-12%"
              ],
              "3": [
                "Killip Class III: Estimated 30-day mortality: 10-20%"
              ],
              "4": [
                "Killip Class IV: Estimated 30-day mortality: 10-20%"
              ]
            }
          ],
          "notes": {
            "type": "unordered-list",
            "content": [
              "Killip Classification quantifies the severity of heart failure in patients with Acute Coronary Syndrome and predicts 30-day mortality",
              "Calculator can be used in both STEMI and NSTEMI patients",
              "Mortality rates have declined significantly since the original study published by Killip and Kimball in 1967",
              "30-day mortality estimates are based on Khot 2003 publication which combined Class III/IV due to a smaller number of patients in Class IV (0.3% of patients)"
            ]
          },
          "references": {
            "type": "ordered-list",
            "content": [
              "Killip T, Kimball J. Treatment of myocardial infarction in a coronary care unit. Am J Cardiol. 1967; 20(4):457-64",
              "Khot UN, Jia G, Moliterno DJ et al. Prognostic importance of physical examination for heart failure in non-ST elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003;Oct 22;290(16):2174-81."
            ]
          }
        }
      ]
    },
    {
      "id": "mods-score-multiple-organ-dysfunction",
      "title": "MODS Score: Multiple Organ Dysfunction",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria"
        },
        {
          "group": "paO2/FiO2 Ratio",
          "data": [
            {
              "type": "radio",
              "label": "300-1000",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "226-299",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "151-225",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "76-150",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "0-75",
              "points": "4"
            }
          ]
        },
        {
          "group": "Platelet Count (10^3/mm^3)",
          "data": [
            {
              "type": "radio",
              "label": ">120",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "81-120",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "51-80",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "21-50",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "≤20",
              "points": "4"
            }
          ]
        },
        {
          "group": "Serum Billirubin",
          "data": [
            {
              "type": "radio",
              "label": "≤1.2mg/dL or 20µmol/L",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "1.3-3.5mg/dL or 21-60µmol/L",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "3.6-7.0mg/dL or 6-120µmol/L",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "7.0-14mg/dL or 121-240µmol/L",
              "points": "3"
            },
            {
              "type": "radio",
              "label": ">14mg/dL or 240µmol/L",
              "points": "4"
            }
          ]
        },
        {
          "group": "Pressure adjusted heart rate (HR x CVP/MAP)",
          "data": [
            {
              "type": "radio",
              "label": "0-10",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "10.1-15",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "15.1-20",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "20.1-30",
              "points": "3"
            },
            {
              "type": "radio",
              "label": ">30",
              "points": "4"
            }
          ]
        },
        {
          "group": "Glasgow Coma Scale",
          "data": [
            {
              "type": "radio",
              "label": "15",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "13-14",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "10-12",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "7-9",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "≤6",
              "points": "4"
            }
          ]
        },
        {
          "group": "Serum Creatinine",
          "data": [
            {
              "type": "radio",
              "label": "≤1.1mg/dL or 100µmol/L",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "1.2-2.2mg/dL or 101-200µmol/L",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "2.3-3.9mg/dL or 201-350µmol/L",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "4.0-5.7mg/dL or 351-500µmol/L",
              "points": "3"
            },
            {
              "type": "radio",
              "label": ">5.7mg/dL or 500µmol/L",
              "points": "4"
            }
          ]
        }
      ],
      "results": [
        {
          "0": [
            "ICU Mortality 0%, Hospital Mortality 0%, ICU Stay 2 days"
          ],
          "1 - 4": [
            "ICU Mortality 1-2%, Hospital Mortality 7%, ICU Stay 3 days"
          ],
          "5 - 8": [
            "ICU Mortality 3-5%, Hospital Mortality 16%, ICU Stay 6 days"
          ],
          "9 - 12": [
            "ICU Mortality 25%, Hospital Mortality 50%, ICU Stay 10 days"
          ],
          "13 - 16": [
            "ICU Mortality 50%, Hospital Mortality 70%, ICU Stay 17 days"
          ],
          "17 - 20": [
            "ICU Mortality 75%, Hospital Mortality 82%, ICU Stay 21 days"
          ],
          "21 - 24": [
            "ICU Mortality 100%, Hospital Mortality 100%"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "MODS Score is used to determine ICU and hospital mortality and average ICU stay for patients with multiple organ failure",
          "Ratio between partial pressure of Oxygen and Fraction of inspired Oxyygen is measured directly for patients undergoing mechanical ventilation and is estimated for non-ventilated patients",
          "A simplified version of the MODS Score can be found in the modified Marshall score which uses the diagnosis capacity for organ failure to assess the severity of acute pancreatitis"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Marshall JC, Cook DJ, Christou NV, et. al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995 Oct;23(10):1638-52. Review.",
          "Nawaz H, Mounzer R, Yadav D, Yabes JG, Slivka A, Whitcomb DC, Papachristou GI. (2013) Revised Atlanta and determinant-based classification: application in a prospective cohort of acute pancreatitis patients. Am J Gastroenterol; 108(12):1911-7.",
          "Jacobs S, Zuleika M, Mphansa T. (1999) The Multiple Organ Dysfunction Score as a descriptor of patient outcome in septic shock compared with two other scoring systems. Crit Care Med; 27(4):741-4."
        ]
      }
    },
    {
      "id": "centor-score-strep-pharyngitis",
      "title": "Centor Score for Strep Pharyngitis (Modified McIsaac)",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Age range",
          "data": [
            {
              "type": "radio",
              "label": "3-14 yrs",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "15-44 yrs",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "≥45yrs",
              "points": "-1"
            }
          ]
        },
        {
          "group": "Exudate or swelling on tonsils",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Tender/Swollen anterior cervical lymph nodes",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Temp >38ºC (100.4ºF)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Cough",
          "data": [
            {
              "type": "radio",
              "label": "Cough present",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Cough Absent",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "-1 - 0": [
            "1%-2.5% likelihood of Strep Pharyngitis; No further testing nor antibiotics"
          ],
          "1": [
            "5%-10% likelihood of Strep Pharyngitis; No further testing nor antibiotics"
          ],
          "2": [
            "11%-17% likelihood of Strep Pharyngitis; Optional rapid strep testing and/or culture"
          ],
          "3": [
            "28%-35% likelihood of Strep Pharyngitis; Consider rapid strep testing and/or culture. IDSA and ASIM no longer recommend empiric treatment for strep based on symptoms alone"
          ],
          "4 - 5": [
            "51%-53% likelihood of Strep Pharyngitis; Consider rapid strep testing and/or culture. IDSA and ASIM no longer recommend empiric treatment for strep based on symptoms alone"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "Centor Score estimates the probability that pharyngitis is streptococcal to help determine which patients to test first",
          "Use this only in patients with recent onset (≤3days) of acute pharyngitis",
          "Most pharyngitis is viral and does not respond to antibiotic treatment",
          "Steroids and NSAIDs can improve symptoms; antibiotics are often indicated in streptococcal pharyngitis but do not prevent the suppurative complications of it like peritonsillar abscess"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239-46.",
          "McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan 13;158(1):75-83."
        ]
      }
    },
    {
      "id": "perc-rule-pulmonary-embolism",
      "title": "PERC Rule for Pulmonary Embolism",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Age ≥ 50yrs",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Heart Rate ≥ 100bpm",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "SaO2 in room air <95%",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Unilateral leg swelling",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Hemoptysis",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Recent surgery or trauma",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Prior Pulmonary Embolism or Deep Vein Thrombosis",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Hormone use (e.g. oral contraceptives, hormone replacement therapy)",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0": [
            "No need for further workup; <2% chance of PE. If no criteria is positive and doctor's pre-test probability is ≤15% then the PERC Rule criteria are satisfied"
          ],
          "1 - 8": [
            "If any criteria are positive then the PERC Rule cannot be used to rule out PE in this patient"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "PERC Rule helps to rule out Pulmonay Embolism if no criteria are present and pre-test probability is ≤15%",
          "If there is a low risk patient who is not PERC negative, consider a d-dimer for further evaluation",
          "If the d-dimer test is negative and clinical gestalt determines a pre-test probability is ≤15% then the patient does not require further testing for PE",
          "If the d-dimer test is positive, further testing such as CT-angiogram or a V/Q scan should be performed"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004 Aug;2(8):1247-55.",
          "Kline JA, Courtney DM, Kabrhel C, Moore CL, Smithline HA, Plewa MC, Richman PB, O'Neil BJ, Nordenholz K. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008 May;6(5):772-80."
        ]
      }
    },
    {
      "id": "ada-diabetes-risk-calculator",
      "title": "ADA Diabetes Risk Calculator",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Age",
          "data": [
            {
              "type": "radio",
              "label": "<40 yrs",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "40-49 yrs",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "50-59 yrs",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≥60 yrs",
              "points": "3"
            }
          ]
        },
        {
          "group": "Gender",
          "data": [
            {
              "type": "radio",
              "label": "Female",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Male",
              "points": "1"
            }
          ]
        },
        {
          "group": "Gestational Diabetes (Female Patients Only)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Hypertension",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes (History of Hypertension, and/or BP ≥140/90 mmHg)",
              "points": "1"
            }
          ]
        },
        {
          "group": "First degree relative with Diabetes",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Physically active",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "BMI",
          "data": [
            {
              "type": "radio",
              "label": "<25",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "25-30",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "30-39",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≥40",
              "points": "3"
            }
          ]
        }
      ],
      "results": [
        {
          "1 - 4": [
            "Not high risk. T2DM screening not recommended by ADA guidelines."
          ],
          "5 - 10": [
            "High risk. Patient should be formally screened for diabetes per ADA guidelines"
          ]
        }
      ],
      "references": {
        "type": "ordered-list",
        "content": [
          "American Diabetes Association: Classification and Diagnosis of Diabetes. Diabetes Care. 2016 Jan;39 Suppl 1:S13-22",
          "Bang H, Edwards AM, Bomback AS, et al. Development and Validation of a Patient Self-assessment Score for Diabetes Risk .Ann Intern Med. 2009;151(11):775-783."
        ]
      }
    },
    {
      "id": "fall-risk-elderly-hospitalized-patients",
      "title": "Fall Risk in Elderly Hospitalized Patients",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "History of fall at presentation or fall since admission",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient displays agitation",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Visually impaired",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Frequent urination",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Patient has poor mobility",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 1": [
            "Risk of falling: 2.4-4.1%"
          ],
          "2 - 5": [
            "Risk of falling: 42 to 65.3%"
          ]
        }
      ],
      "references": {
        "type": "ordered-list",
        "content": [
          "Oliver D, Britton M, Seed P, et. al. Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: case-control and cohort studies. BMJ. 1997 Oct 25;315(7115):1049-1053."
        ]
      }
    },
    {
      "id": "abc-score-massive-blood-transfusion",
      "title": "ABC Score for Massive Blood Transfusion",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Penetrating Mechanism?",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Systolic BP ≥90mmHg?",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Heart Rate ≥120bpm?",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Positive Ultrasound FAST Exam?",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 1": [
            "Less likely to require a massive transfusion (i.e. ≥10 units of packed RBCs)"
          ],
          "2 - 4": [
            "Likely to require massive blood transfusion (i.e. ≥10 units of packed RBCs)"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "Massive transfusion protocols are specific to institution but often are 1:1:1 or 1:1:2 for fresh frozen plasma, platelets and packed Red Blood Cells (JAMA 2015)",
          "The ABC Score helps to predict if trauma patients should receive blood through a massive transfusion protocol but it does not indicate if trauma patients should receive blood"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009 Feb;66(2):346-52.",
          "Cotton BA, Dossett LA, Haut ER, Shafi S, Nunez TC, Au BK, Zaydfudim V, Johnston M, Arbogast P, Young PP. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma. 2010 Jul;69 Suppl 1:S33-9."
        ]
      }
    },
    {
      "id": "acute-gout-diagnosis-rule",
      "title": "Acute Gout Diagnosis Rule",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Criteria",
          "data": [
            {
              "type": "checkbox",
              "label": "Male",
              "points": "2"
            },
            {
              "type": "checkbox",
              "label": "History of Arthritis attack",
              "points": "2"
            },
            {
              "type": "checkbox",
              "label": "Onset ≤1 day",
              "points": "0.5"
            },
            {
              "type": "checkbox",
              "label": "Joint redness",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "1st metatarsophalangeal joint involvement",
              "points": "2.5"
            },
            {
              "type": "checkbox",
              "label": "Hypertension or Cardiac Disease (e.g. MI, Stroke, PVD, CHF, Angina)",
              "points": "1.5"
            },
            {
              "type": "checkbox",
              "label": "Serum uric acid > 0.35 mmol/L or 5.88 mg/dL",
              "points": "3.5"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 4": [
            "Gout is unlikely. Estimated prevalence of gout is 2.2% in original study"
          ],
          "5 - 7": [
            "Estimated prevalence of gout is 31.2%. Patients often benefit the most from synovial fluid analysis for urate crystals"
          ],
          "8 - 13": [
            "Gout arthritis is very likely. Estimated prevalence of gout is 82.5%. Consider starting gout medications. "
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "Gout flares are often treated with some combination of steroids, NSAIDS (classically, indomethacin), opioids for extreme pain, and colchicine.",
          "Management will depend on the patient's age and other risk factors for complications.",
          "After the initial flare, patients may benefit from urate-lowering therapies like allopurinol.",
          "This rule was developed and validated in Europe and may be less applicable to non-European populations"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Hein J. E. M. Janssens, Jaap Fransen, Eloy H. van de Lisdonk, et al. A Diagnostic Rule for Acute Gouty Arthritis in Primary Care Without Joint Fluid Analysis. Arch Intern Med. 2010;170(13):1120-1126",
          "Keinhorst L, Janssens HJM, Fransen J., Janssen M.Comment on: The validation of a diagnostic rule for gout without joint fluid analysis: A prospective study: Reply. Rheumatology (Oxford). 2015 APr;54(4):609-14 "
        ]
      }
    },
    {
      "id": "bishop-score-vaginal-delivery-labor",
      "title": "Bishop Score for Vaginal Delivery and Induction of Labor",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Dilation",
          "data": [
            {
              "type": "radio",
              "label": "Closed",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "1-2cm",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "3-4cm",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≥5cm",
              "points": "3"
            }
          ]
        },
        {
          "group": "Effacement",
          "data": [
            {
              "type": "radio",
              "label": "0-30%",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "40-50%",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "60-70%",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≥80%",
              "points": "3"
            }
          ]
        },
        {
          "group": "Station",
          "data": [
            {
              "type": "radio",
              "label": "-3",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "-2",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "-1, 0",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "+1, +2",
              "points": "3"
            }
          ]
        },
        {
          "group": "Position",
          "data": [
            {
              "type": "radio",
              "label": "Posterior",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Mid-Position",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Anterior",
              "points": "2"
            }
          ]
        }
      ],
      "results": [
        {
          "1 - 5": [
            "Unfavorable cervix. Induction may be necessary for successful vaginal delivery"
          ],
          "6 - 7": [
            "No definitive prediction on whether induction will be successful. Consider induction or augmentation of labor based on clinical judgement"
          ],
          "8 - 13": [
            "Spontaneous vaginal delivery is more likely. Augmentation and induction may be unnecessary"
          ]
        }
      ],
      "notes": {
        "type": "unordered-list",
        "content": [
          "Bishop Score helps to predict the likelihood of successful vaginal delivery",
          "Induction is often considered at Bishop Score ≤ 5 points"
        ]
      },
      "references": {
        "type": "ordered-list",
        "content": [
          "Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol. 1964 Aug;24:266-8.",
          "Newman RB et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol. 2008 Sep;112(3):508-15"
        ]
      }
    },
    {
      "id": "chalice-rule-child-head-injury",
      "title": "CHALICE Rule for Child Head Injury",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "History",
          "data": [
            {
              "type": "checkbox",
              "label": "Witnessed LOC > 5min",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Amnesia > 5min",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Abnormal drowsiness",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "≥3 vomit episodes after head injury",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Suspicion of non-accidental injury",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Seizure after head injury (no previous Epilepsy history)",
              "points": "1"
            }
          ]
        },
        {
          "group": "Examination",
          "data": [
            {
              "type": "checkbox",
              "label": "Glasgow Coma Scale <14 (or GCS <15 if <1 yr old)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Suspicion of penetrating or depressed skull injury",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Signs of basal skull fracture (e.g. Blood or CSF from ear or nose, Panda eyes, Serious facial injury)",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Positive focal neurologic sign",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Bruises, swelling or laceration >5cm (if <1 yr old)",
              "points": "1"
            }
          ]
        },
        {
          "group": "Mechanism",
          "data": [
            {
              "type": "checkbox",
              "label": "High speed road accident (> 64kmph or 40mph) as pedestrian, cyclist or car occupant",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "Fall of >3m in height",
              "points": "1"
            },
            {
              "type": "checkbox",
              "label": "High speed injury from a projectile or object",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0": ["Low risk of intracranial pathology. CT not necessary"],
          "1 - 14": ["Not low risk. Consider CT"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "Use in children <16 years with history or signs of head injury",
            "Consider the PECARN Pediatric Head Injury score as it is the most widely validated"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Dunning J, Daly JP, Lomas JP, Lecky F, Batchelor J, Mackway-Jones K, Derivation of the children's head injury algorithm for the prediction of important clinical events decision rule for head injury in children.Arch Dis Child. 2006 Nov;91(11):885-91."
          ]
        }
      ]
    },
    {
      "id": "burch-wartofsky-point-scale-thyrotoxicosis",
      "title": "Burch-Wartofsky Point Scale for Thyrotoxicosis",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Temperature",
          "data": [
            {
              "type": "radio",
              "label": "37.2-37.7°C (99-99.9°F)",
              "points": "5"
            },
            {
              "type": "radio",
              "label": "37.8-38.2°C (100-100.9°F)",
              "points": "10"
            },
            {
              "type": "radio",
              "label": "38.3-38.8°C (101-101.9°F)",
              "points": "15"
            },
            {
              "type": "radio",
              "label": "38.9-39.2°C (102-102.9°F)",
              "points": "20"
            },
            {
              "type": "radio",
              "label": "39.3-39.9°C (103-103.9°F)",
              "points": "25"
            },
            {
              "type": "radio",
              "label": "≥40°C (≥104°F)",
              "points": "30"
            }
          ]
        },
        {
          "group": "Central Nervous System Effects",
          "data": [
            {
              "type": "radio",
              "label": "Absent",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Mild (Agitation)",
              "points": "10"
            },
            {
              "type": "radio",
              "label": "Moderate (Seizures, coma)",
              "points": "20"
            },
            {
              "type": "radio",
              "label": "Severe (Seizures, coma)",
              "points": "30"
            }
          ]
        },
        {
          "group": "Gastrointestinal-hepatic dysfunction",
          "data": [
            {
              "type": "radio",
              "label": "Absent",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Moderate (Diarrhea, Nausea/vomiting, Abdominal pain)",
              "points": "10"
            },
            {
              "type": "radio",
              "label": "Severe (Unexplained jaundice)",
              "points": "15"
            }
          ]
        },
        {
          "group": "Congestive Heart Failure",
          "data": [
            {
              "type": "radio",
              "label": "Absent",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Mild (Pedal Edema)",
              "points": "5"
            },
            {
              "type": "radio",
              "label": "Moderate (Bibasilar rales)",
              "points": "10"
            },
            {
              "type": "radio",
              "label": "Severe (Pulmonary Edema)",
              "points": "15"
            }
          ]
        },
        {
          "group": "Heart Rate",
          "data": [
            {
              "type": "radio",
              "label": "90-109 bpm",
              "points": "5"
            },
            {
              "type": "radio",
              "label": "110-119 bpm",
              "points": "10"
            },
            {
              "type": "radio",
              "label": "120-129 bpm",
              "points": "15"
            },
            {
              "type": "radio",
              "label": "130-139 bpm",
              "points": "20"
            },
            {
              "type": "radio",
              "label": "≥140 bpm",
              "points": "25"
            }
          ]
        },
        {
          "group": "Atrial Fibrillation",
          "data": [
            {
              "type": "radio",
              "label": "None",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Present",
              "points": "10"
            }
          ]
        },
        {
          "group": "Precipitating Event",
          "data": [
            {
              "type": "radio",
              "label": "None",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "10"
            }
          ]
        }
      ],
      "results": [
        {
          "10 - 24": ["Unlikely to represent thyroid storm. Investigate diagnosis of thyrotoxicosis and obtain additional imaging (e.g. thyroid ultrasound, radioactive iodine uptake and scan)"],
          "25 - 44": ["Impending thyroid storm. Consider thionamides and symptom management along with ICU monitoring"],
          "45 - 140": ["Highly suggestive of thyroid storm. Consider rapid and aggressive multimodal management in ICU"]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993 Jun;22(2):263-77."
          ]
        }
      ]
    },
    {
      "id": "mmrc-dyspnea-scale",
      "title": "mMRC Dyspnea Scale",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Symptom severity",
          "data": [
            {
              "type": "radio",
              "label": "Dyspnea only with strenuous exercise",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Dyspnea when hurrying or walking up a slight hill",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Walks slower than people of similar age due to dyspnea or has to stop for breath when walking at own pace",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "Stops for breath after walking 91m (100 yards) or after a few min",
              "points": "3"
            },
            {
              "type": "radio",
              "label": "Too dyspneic to leave house or breathless when dressing",
              "points": "4"
            }
          ]
        }
      ],
      "results": [
            {
              "0": ["Grade 0"],
              "1": ["Grade 1"],
              "2": ["Grade 2"],
              "3": ["Grade 3"],
              "4": ["Grade 4"]
            }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "The mMRC Dyspnea scale is best used to establish baseline functional impairment caused by dyspnea",
            "The mMRC is correlated with morbidity and mortality for patients with respiratory disease, but there is no evidence that confirms attributable cause and effect between mMRC Dyspnea scale scores and patient centered outcomes",
            "The score must be contextualized with an individual patient's history, physical and available diagnostic test results",
            "For patients with higher mMRC grade ≥2 and clinical findings consistent with respiratory disease, consider spirometry (FEV1 and FVC), determining the patient's BODE index and/or GOLD stage as well as targeted diagnostic and/or therapeutic interventions"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Mahler DA, Wells CK, Evaluation of clinical methods for rating dyspnea. Chest. 1988 Mar;93(3):580-6",
            "Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir. Crit. Care Med. 1998 Oct;158(4):1185-9."
          ]
        }
      ]
    },
    {
      "id": "rule-of-sevens-lyme-meningitis",
      "title": "Rule of 7s for Lyme Meningitis",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Number of days of headache",
          "data": [
            {
              "type": "radio",
              "label": "<7",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "≥7",
              "points": "1"
            }
          ]
        },
        {
          "group": "CSF Mononuclear cells",
          "data": [
            {
              "type": "radio",
              "label": "<70%",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "≥70%",
              "points": "1"
            }
          ]
        },
        {
          "group": "7th (or other) Cranial Nerve Palsy",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0": ["Low risk for Lyme Meningitis. Antibiotics not recommended, consider close patient follow-up and use clinical judgement regarding patient disposition"],
          "1 - 3": ["Not low risk for Lyme Meningitis. Consider antibiotics to cover Borrelia burgdoreferi"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
              "Rule of 7s is used to assist in distinguishing Lyme meningitis from aseptic meningitis and to start antibiotics for suspected Lyme",
              "Use in pediatric patients (2-18 years) in a Lyme endemic area with CSF pleocytosis, defined as CSF WBC ≥ 10 cells/mm^3 (corrected for CSF RBC if >500 using a ratio of 1 WBC for every 500 RBC)"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Garro AC, Rutman M, Simonsen K, Jaeger JL, Chapin K, Lockhart G. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics. 2009 May;123(5):e829-34.",
            "Cohn KA, Thompson AD, et al. Validation of a Clinical Prediction Rule to Distinguish Lyme Meningitis From Aseptic Meningitis. Pediatrics. 2012; 129(1):e46-53"
          ]
        }
      ]
    },
    {
      "id": "bap-65-score-acute-exacerbation-copd",
      "title": "BAP-65 Score for Acute Exacerbation of COPD",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "BUN ≥ 8.9 mmol/L (25mg/dL)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Altered mental status (GCS <14, disorientation, stupor, coma)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Pulse rate ≥ 109bpm",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Age",
          "data": [
            {
              "type": "radio",
              "label": "41-64 yrs",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "0.5"
            }
          ]
        }
      ],
      "results": [
        {
          "0": ["Class I; BAP 0, Age <65 years. Routine management of COPD exacerbation. In-hospital mortality 0.3% with 0.3% requiring intubation within 48 hrs"],
          "0.5": ["Class II; BAP 0, Age ≥65 years. Routine management of COPD exacerbation. In-hospital mortality 1% with 0.2% requiring intubation within 48 hrs"],
          "1": ["Class III; BAP 1, Any age >40. Consider early non-invasive ventilation and/or ICU care. In-hospital mortality 2.2% with 1.2% requiring intubation within 48 hrs"],
          "2": ["Class IV; BAP 2, Any age >40. Consider early non-invasive ventilation and/or ICU care. In-hospital mortality 6.4% with 5.5% requiring intubation within 48 hrs"],
          "3": ["Class V; BAP 3, Any age >40. Consider early non-invasive ventilation, close monitoring and/or ICU care. In-hospital mortality 14.1% with 12.4% requiring intubation within 48 hrs"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "The BAP-65 score should be used in patients >40 years of age that present to the emergency department with acute COPD exacerbation.",
            "Data for in-hospital mortality comes from the validation study Tabak 2009",
            "BAP-65 Class V patients have the highest risk of in-hospital mortality and need for mechanical ventilation. These patients should be closely monitored"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Tabak YP, Sun X, Johannes RS, et al. Mortality and Need for Mechanical Ventilation in Acute Exacerbations of Chronic Obstructive Pulmonary Disease Development and Validation of a Simple Risk Score. Arch Intern Med. 2009;169(17):1595-1602.",
            "Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011 Nov;140(5):1177-1183"
          ]
        }
      ]
    },
    {
      "id": "san-francisco-syncope-rule",
      "title": "San Francisco Syncope Rule",
      "type": "points",
      "questions": [
        {
          "group":"History of Congestive Heart Failure",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Hematocrit <30%",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Abnormal ECG (Non-sinus rhythm or ECG changed)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Shortness of Breath",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Systolic BP <90 mmHg at triage",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0": ["Patient is in low-risk group for serious outcome"],
          "1 - 5": ["Patient is not in the low-risk group for serious outcome (96% sensitivity, 62% specificity); Negative predictive value 99.2%, Positive predictive value 24.8%"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "Use the SF Syncope Rule to stratify the risk of patients with unexplained syncope",
            "Serious outcome in this study is defined as death, myocardial infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant hemorrahge or any condition causing a return Emergency Department visit and hospitalization for a related event"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May;47(5):448-54.",
            "Birnbaum A, Esses D, Bijur P, Wollowitz A, Gallagher EJ. Failure to validate the San Francisco Syncope Rule in an independent emergency department population. Ann Emerg Med. 2008 Aug;52(2):151-9."
          ]
        }
      ]
    },
    {
      "id": "pediatric-appendicitis-score",
      "title": "Pediatric Appendicitis Score",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group":"RLQ tenderness to cough, percussion or hopping",
          "data": [
            {
            "type": "radio",
            "label": "No",
            "points": "0"
            },
            {
            "type": "radio",
            "label": "Yes",
            "points": "2"
            }
          ]
        },
        {
          "group":"Anorexia",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Nausea or vomiting",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Fever ≥38°C or 100.4°F",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Tenderness over right iliac fossa",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "2"
            }
          ]
        },
        {
          "group":"Leukocytosis WBC >10,000",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Migration of pain to Right Lower Quadrant",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group":"Left shift Absolute Neutrophil Count >7500",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 3": ["Appendicitis is unlikely. Consider other diagnoses"],
          "4 - 6": ["Cannot definitively rule in or rule out appendicitis. Consider ultrasound or MRI imaging and/or surgical consult"],
          "6 - 10": ["Appendicitis is likely. Consider surgical consult and imaging; Patients should only undergo ultrasound prior to surgical consult"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "PAS Score can be used to estimate risk of appendicitis in children",
            "For patients who are not at low risk, next steps include NPO status, IV fluids, analgesia and imaging or surgical consult",
            "Patients in low risk group according to the PAS do not have a zero risk. Use clinical judgement if imaging or surgical consult may aid in diagnosis"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Samuel M. Pediatric Appendicitis Score. Journal of Pediatric Surgery, Vol 37; No6(June), 2002:pp 877-881",
            "Goldman RD. The Paediatric Appendicitis Score (PAS) was useful in children with acute abdominal pain. Evid Based Med 2009; 14:26"
          ]
        }
      ]
    },
    {
      "id": "dragon-score-post-tpa-stroke-outcome",
      "title": "DRAGON Score for Post-TAP Stroke Outcome",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "HyperDense Cerebral Artery/Early Infarct on CT scan",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Either",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "Both",
              "points": "2"
            }
          ]
        },
        {
          "group": "Modified Rankin Scale >1, Prestroke",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Either",
              "points": "1"
            }
          ]
        },
        {
          "group": "Age",
          "data": [
            {
              "type": "radio",
              "label": "<65 yrs",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "65-79 yrs",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "≥80 yrs",
              "points": "2"
            }
          ]
        },
        {
          "group": "Onset of Treatment >90 min",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Glucose at Baseline >8mmol/L (144 mg/dL)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Baseline NIH Stroke Scale",
          "data": [
            {
              "type": "radio",
              "label": "0-4",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "5-9",
              "points": "1"
            },
            {
              "type": "radio",
              "label": "10-15",
              "points": "2"
            },
            {
              "type": "radio",
              "label": "≥16",
              "points": "3"
            }
          ]
        }
      ],
      "results": [
        {
          "0 - 1": [">99% likelihood of a good outcome (mRS 0-2); 0% likelihood of a miserable outcome (mRS 5-6)"],
          "2": [">96% likelihood of a good outcome (mRS 0-2); 2% likelihood of a miserable outcome (mRS 5-6)"],
          "3": [">87% likelihood of a good outcome (mRS 0-2); 7% likelihood of a miserable outcome (mRS 5-6)"],
          "4": [">81% likelihood of a good outcome (mRS 0-2)"],
          "5": [">83% likelihood of a miserable outcome (mRS 5-6)"],
          "6": [">90% likelihood of a miserable outcome (mRS 5-6)"],
          "7": [">97% likelihood of a miserable outcome (mRS 5-6)"],
          "8 - 10": ["0% likelihood of a good outcome (mRS 0-2); >99% likelihood of a miserable outcome (mRS 5-6)"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "The DRAGON Score is used to predict 3 month outcomes in ischemic stroke patients receiving intravenous thrombolysis (tPA)",
            "For patients with a DRAGON score that predicts a miserable outcome even if tPA is given, consider the risk/benefit of giving IV thrombolytics",
            "These patients may be potential candidates for endovascular thrombectomy, although the benefits of this procedure have not yet been demonstrated in literature"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, Engelter S, Tatlisumak T. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012 Feb 7;78(6):427-32.",
            "Strbian D, Seiffge DJ, Breuer L, et al. Validation of the DRAGON Score in 12 Stroke Centers in Anterior and Posterior Circulation.Stroke. 2013;STROKEAHA.113.002033"
          ]
        }
      ]
    },
    {
      "id": "vancouver-chest-pain-rule",
      "title": "Vancouver Chest Pain Rule",
      "type": "points",
      "points": 0,
      "questions": [
        {
          "group": "Step 1:"
        },
        {
          "group": "Abnormal initial ECG (e.g. ST elevation, ST depression >0.5mm, Q waves, LVH, paced rhythm or LBBB)",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Positive troponin at 2 hours",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Prior ACS or nitrate use",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Step 2 (Only if Step 1 answers are all No):"
        },
        {
          "group": "Does palpation reproduce pain?",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "4"
            }
          ]
        },
        {
          "group": "Step 3 (Only if Step 2 answer is No):"
        },
        {
          "group": "Age ≥50 years",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "0"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "1"
            }
          ]
        },
        {
          "group": "Does pain radiate to neck, jaw or left arm?",
          "data": [
            {
              "type": "radio",
              "label": "No",
              "points": "5"
            },
            {
              "type": "radio",
              "label": "Yes",
              "points": "5"
            }
          ]
        }
      ],
      "results": [
        {
          "0": ["Low risk for adverse event. Candidate for early discharge"],
          "1 - 3": ["Standard Evaluation. This patient is not a candidate for early discharge and should receive a standard chest pain evaluation"],
          "4": ["Low risk if chest pain is reproducible. Candidate for early discharge. Step 3 is not required."],
          "5 - 10": ["Standard Evaluation. This patient is not a candidate for early discharge and should receive a standard chest pain evaluation"]
        }
      ],
      "notes": [
        {
          "type": "unordered-list",
          "content": [
            "Vancouver Chest Pain Rule identifies chest pain patients who are at low risk and candidates for early discharge",
            "If the answers to Step 1 are no to all, move to Step 2. Otherwise proceed with chest pain evaluation",
            "If the answer to Step 2 is yes, proceed to early discharge. If no, move to Step 3",
            "If the answers to Step 3 are no to all, proceed to early discharge. If not, proceed with chest pain evaluation"
          ]
        }
      ],
      "references": [
        {
          "type": "ordered-list",
          "content": [
            "Scheuermeyer FX, Wong H, Yu E, Boychuk B, Innes G, Grafstein E, Gin K, Christenson J.Development and validation of a prediction rule for early discharge of low-risk emergency department patients with potential ischemic chest pain. CJEM. 2014 Mar;16(2):106-19."
          ]
        }
      ]
    }
  ]
}



